Thyroid hormone availability and action during brain development in rodents by Bárez-López, S. & Guadaño-Ferraz, A.
                          Bárez-López, S., & Guadaño-Ferraz, A. (2017). Thyroid hormone
availability and action during brain development in rodents. Frontiers in
Cellular Neuroscience, 11, [240]. https://doi.org/10.3389/fncel.2017.00240
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.3389/fncel.2017.00240
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Frontiers at
https://www.frontiersin.org/articles/10.3389/fncel.2017.00240/full. Please refer to any applicable terms of use of
the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
MINI REVIEW
published: 14 August 2017
doi: 10.3389/fncel.2017.00240
Thyroid Hormone Availability and
Action during Brain Development in
Rodents
Soledad Bárez-López1,2* and Ana Guadaño-Ferraz1,2
1Department of Endocrine and Nervous System Pathophysiology, Instituto de Investigaciones Biomédicas Alberto Sols,
Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid (UAM), Madrid, Spain, 2Center for
Biomedical Research on Rare Diseases (Ciberer), Instituto de Salud Carlos III, Madrid, Spain
Edited by:
Davide Cervia,
Università degli Studi della Tuscia,
Italy
Reviewed by:
Gabor Wittmann,
Tufts Medical Center, United States
Mario Valentino,
University of Malta, Malta
*Correspondence:
Soledad Bárez-López
sbarez@iib.uam.es
Received: 14 June 2017
Accepted: 31 July 2017
Published: 14 August 2017
Citation:
Bárez-López S and
Guadaño-Ferraz A (2017) Thyroid
Hormone Availability and Action
during Brain Development in
Rodents.
Front. Cell. Neurosci. 11:240.
doi: 10.3389/fncel.2017.00240
Thyroid hormones (THs) play an essential role in the development of all vertebrates; in
particular adequate TH content is crucial for proper neurodevelopment. TH availability
and action in the brain are precisely regulated by several mechanisms, including the
secretion of THs by the thyroid gland, the transport of THs to the brain and neural
cells, THs activation and inactivation by the metabolic enzymes deiodinases and, in
the fetus, transplacental passage of maternal THs. Although these mechanisms have
been extensively studied in rats, in the last decade, models of genetically modified
mice have been more frequently used to understand the role of the main proteins
involved in TH signaling in health and disease. Despite this, there is little knowledge
about the mechanisms underlying THs availability in the mouse brain. This mini-review
article gathers information from findings in rats, and the latest findings in mice regarding
the ontogeny of TH action and the sources of THs to the brain, with special focus on
neurodevelopmental stages. Unraveling TH economy and action in the mouse brain
may help to better understand the physiology and pathophysiology of TH signaling in
brain and may contribute to addressing the neurological alterations due to hypo and
hyperthyroidism and TH resistance syndromes.
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INTRODUCTION
Thyroid hormones (THs) are essential for the correct development of vertebrates controlling
cell growth and metabolism in all tissues. The developing CNS is particularly sensitive to
impairments in TH signaling. It is well known that TH deficit leads to numerous alterations the
severity of which depends on the timing and the cause of the hormonal deficit (Morreale de
Escobar et al., 2004; Zoeller and Rovet, 2004). While the wide range of clinical manifestations
of adult onset hypothyroidism are usually reversed with an appropriate treatment, THs deficit
during development can lead to irreversible neurological alterations unless treated with a timely
Abbreviations: BBB, blood brain barrier; BCSFB, blood-cerebrospinal fluid barrier; D2, deiodinase type-2;
D3, deiodinases type-3; E, embryonic day; MCT8, monocarboxylate transporter 8; Oatp1c1, organic anion transporter
family member 1C1; P, postnatal day; T3, 3,5,3′-triodo-L-thyronine; T4, 3,5,3′,5′-tetraiodo-L-thyronine; THs, thyroid
hormones; TRs, thyroid hormone receptors.
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initiation of hormonal replacement therapy (Morreale de
Escobar et al., 2000), highlighting the importance of both
appropriate levels of THs and timing of action.
THs are synthesized in the thyroid gland. Out of the total
hormonal secretion of the thyroid gland approximately 93%
is as thyroxine or 3,5,3′,5′-tetraiodo-L-thyronine (T4) and 7%
as 3,5,3′-triodo-L-thyronine (T3) which is the active nuclear
form (Bernal, 2015). The main pathway of THs action is at the
genomic level by regulating gene expression through the binding
of T3 to nuclear TH receptors (TRs) which function as ligand-
modulated transcription factors (Cheng et al., 2010). In the brain
deiodinases (D2 and D3) play an essential role in maintaining
appropriate levels of T3. D2 catalyzes the conversion of T4 into
the genomically active T3 while D3 catalyzes the deiodination of
T4 and T3 into 3,3′5′-triiodo-L-thyronine (rT3) and 3,3′-diiodo-
Lthyronine (T2) respectively, inactivating TH action (Bianco and
Kim, 2006). Another crucial step for TH action is the transport
of THs across the brain barriers and the plasma membrane of
target cells by TH membrane transporter proteins. Among the
many TH transporters that have been shown to mediate TH
transport, the monocarboxylate transporter 8 (MCT8) presents
the highest specificity for THs. Mutations in this transporter lead
to the Allan-Herndon-Dudley syndrome with severe endocrine
and neurological alterations (Visser, 2007; Fu et al., 2013; Bernal,
2015). In view of this, several regulatory mechanisms fine-tune
the brain content of T4 and T3. These include TH secretion by
the thyroid gland, TH transport to the brain and neural cells,
activity of deiodinases, and in the fetus, transplacental passage of
maternal THs (Obregon et al., 1984; Morreale de Escobar et al.,
1990).
Most of the knowledge regarding TH action in the developing
brain has arisen from studies in rats. However, due to the
advantages of using genetic engineering approaches to generate
genetically modified animals in mice over rat, the mouse has
become the most widely used model to study thyroid physiology
and TH action in brain. The use of genetically modified
mice is providing new insights into thyroid physiological and
pathological events. Despite this, many events underlying TH
availability in the brain during mouse fetal development still
need to be unraveled in order to fully understand TH economy
in the developing brain. The aim of this review is to give
an up-to-date insight into the evidence that has led to the
understanding of TH availability and action in the developing
brain of both rats and mice especially during embryonic
stages.
ONTOGENY OF THYROID HORMONE
ACTION
In the rat, tissues from whole embryos are provided with small
amounts of T4 and T3 from at least embryonic day 11 (E11;
Obregon et al., 1984), well before the onset of fetal thyroid gland
function, which starts after E17. As the fetal thyroid gland starts
functioning, the proportion of fetal THs increases so at term
around 17.5% of the fetal pool of T4 (Morreale de Escobar et al.,
1990) and 47% of the fetal pool of T3 are of maternal origin
(Grijota-Martínez et al., 2011). In the mouse, the contribution
of maternal T4 at term is larger than in rats as 60% of the total
TH content in peripheral tissues derive directly from the mother
(Bárez-López et al., 2017b).
The few studies reporting T3 and T4 content in the developing
rat brain have been restricted to periods coinciding with
or following the onset of fetal thyroid function at E17–E21
(Morreale de Escobar et al., 1985; Ruiz De Oña et al., 1988;
Figure 1). In mice, T4 content in brain has been detected from at
least E16 (Dong et al., 2015) which is just before the onset of the
fetal thyroid gland that in mice starts around E16.5 (Fernández
et al., 2015), and T3 has been detected from at least E18 (Ferrara
et al., 2013; Bárez-López et al., 2017b).
In the rat, mRNA for TRs has been detected from E11.5 at
the neural tube and from E12.5 in certain areas of the
prosencephalon, mesencephalon and the rhombencephalon
(Bradley et al., 1992). In addition, T3 binding assays have
revealed the presence of TRs in brain from E14, preceding the
development of thyroid function, and their concentration has
been shown to increase progressively until E17 (Perez-Castillo
et al., 1985). Furthermore, at least from E21 there is a T3 receptor
occupancy of 38% (Ferreiro et al., 1990; Figure 1). To our
knowledge there are no studies describing the expression of TRs
in the fetal mouse brain.
In the rat, deiodinase activity assays have detected D2 in the
brain from as early as E17 with increasing activity until the day
prior to birth (Ruiz De Oña et al., 1991; Figure 1). In the mouse,
Dio2 mRNA expression has been detected in the brain from at
least E15 (Bárez-López et al., 2017b), suggesting that maternal
THs are necessary in the fetal brain before the maturation of the
fetal thyroid gland. Interestingly, D2 and D3 are developmentally
regulated in the brain (Bates et al., 1999; Escámez et al., 1999;
Guadaño-Ferraz et al., 1999) as during the rat early postnatal
development the maturational patterns of D2 and D3 activities
reveal a progressive increase in D2 activity while D3 activity
follows the opposite pattern (Kaplan and Yaskoski, 1981).
Regarding TH transporters there are no studies describing
their spatiotemporal expression pattern during embryonic
development in neither rats nor mice. There is a very
complete study describing in detail the expression pattern
of the main TH transporters in the mouse brain (Mct8,
organic anion transporter family member 1c1 (Oatp1c1), L-type
amino acid transporter 1, L-type amino acid transporter 2
and monocarboxylate transporter 10) from postnatal day 6
(P6) and this study revealed a precise mRNA expression
pattern for each of the transporters which changed with
age (Müller and Heuer, 2014). Other physiological studies
have demonstrated that Mct8-deficient mice present a state
of brain hyperthyroidism from E18 until P5 and that the
combined inactivation of Mct8 and Lat2 suppresses this
hyperthyroidism (Ferrara et al., 2013; Núñez et al., 2014)
suggesting a crucial role for TH transporters in brain TH
homeostasis. The dynamic expression of TH transporters in the
brain as well as the functional implications of their deficiency
highlights the relevance of TH transporters activity during fetal
neurodevelopment and the consequent need to increase our
understanding of their spatiotemporal expression pattern and
function.
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FIGURE 1 | Ontogenesis of thyroid hormone action during fetal brain development in the rat. In the rat brain, thyroid hormone receptors (TRs) mRNA expression is
detected from E11.5 and TRs from E14. D2 activity in addition to 3,5,3′,5′-tetraiodo-L-thyronine (T4) and 3,5,3′-triodo-L-thyronine (T3) content are present in the rat
fetal brain from at least E17 when the onset of fetal thyroid function takes place. D2 activity, T4 and T3 content progressively increase in the rat fetal brain from
E17 until E21. The size of the figures does not represent relative abundance. Most of these events remain to be fully elucidated in the mouse.
SOURCES OF THYROID HORMONES TO
THE RODENT BRAIN
The main source of T3 in the brain is provided by the local
conversion of T4 into T3 by D2 as, in the adult rat brain, 80%
of nuclear bound T3 is formed locally from T4 (Crantz et al.,
1982). Further studies in adult hypothyroid rats revealed that
constant infusion of T3 at relatively low doses was enough to
normalize T3 levels in peripheral tissues while much higher doses
were necessary for the cerebral cortex (CCx) to reach normal
values. On the other hand, when T4 was administered, T3 values
were normalized in the CCx at lower doses than those necessary
to restore T3 levels in other peripheral tissues. Furthermore,
T3 content in the CCx remained within the physiological range
regardless of the increase in the dose of the T4 administered
(Escobar-Morreale et al., 1999). These studies revealed that T4 is
the primary source of T3 in the brain and that local conversion of
T4 into T3 is tightly regulated avoiding excess of T3. A previous
study had proposed a close metabolic coupling between glial cells
and neurons by which T4 would be taken up from the blood
and the cerebrospinal fluid by astrocytes and tanycytes, where it
would be deiodinated into T3 by D2 activity, and would finally
be released for utilization by neurons (Guadaño-Ferraz et al.,
1997). Years later, studies with transgenic mice validated and
completed this model for T3 availability to neural cells (Ceballos
et al., 2009; Freitas et al., 2010; Morte et al., 2010a). Currently,
the model states that brain T3 has a double origin: a fraction is
available directly from the circulation, and another is produced
locally from T4 in the astrocytes by D2. To enter the brain,
circulating T4 and T3 need to cross the brain barriers through
specific TH transporters. Based on the transporters’ location the
current model in rodents indicates that: (i) T3 and T4 cross
the blood-brain barrier (BBB) through Mct8 (Dumitrescu et al.,
2006; Trajkovic et al., 2007) into the extracellular fluid where they
can directly reach the neural cells in the proximity of the blood
vessels; and that (ii) T4, but not T3, crosses the BBB through the
Oatp1c1 (Mayerl et al., 2014) directly into the astrocytes through
their end-feet in contact with the blood vessels, and astrocytes
produce additional T3 by D2 activity that can be then transported
to the neurons (reviewed in Morte and Bernal, 2014).
For the postnatal and adult brain, studies in transgenic mice
suggest that each of these two routes can contribute to at least
50% of the total pool of brain T3. D2-deficient mice present
around a 50% decrease in the content of T3 in the CCx at
P15 (Galton et al., 2007) and 40% decrease at 3 months of age
(Bárez-López et al., 2014). Furthermore, Mct8-deficient mice
also present a 50% reduction in the content of T3 in the CCx
(Dumitrescu et al., 2006; Trajkovic et al., 2007). Together these
data suggest that in the mice postnatal brain around 50% of
the total brain T3 derives directly from T3 uptake from the
circulation and another 50% is locally generated in the astrocytes
from T4.
In contrast, studies in rats demonstrated that during fetal
development the brain depends almost entirely on the T3 locally
generated by D2. A pioneer study demonstrated that infusion
of T4 to hypothyroid pregnant rats was sufficient to increase
T3 content in the fetal brain to similar values of control fetuses
while T3 concentrations increased very little in plasma and lung
(Morreale de Escobar et al., 1988). Subsequent studies evidenced
that the high doses of T3 administered to hypothyroid pregnant
rats were able to cross the placenta but failed to normalize
T3 content in the fetal brain and to induce the expression
of T3-dependent genes. In contrast, physiological doses of
T4 could cross both the placenta and the fetal brain barriers,
normalizing fetal brain T3 concentrations by T4 deiodination
and increasing neuronal gene expression (Calvo et al., 1990;
Grijota-Martínez et al., 2011). The role of D2 activity in this
process is further supported by D2 activity ontogeny studies
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FIGURE 2 | Proposed model of T3 availability to the mouse developing brain. T4 mostly of maternal origin reaches the brain, gets transported into the cerebrospinal
fluid and converted into T3 by D2 (in red) at the blood-cerebrospinal fluid barrier (meninges and choroid plexus) and at the lateral ventricles. From the cerebrospinal
fluid the T3 could spread throughout the brain and access the neural cells to exert its action. CFS, cerebrospinal fluid; chp, choroid plexus; LV, lateral ventricles and
mng, meninges.
that revealed significant D2 activity in rat fetal brain which
highly increased prior to birth and was inversely regulated by
increasing doses of T4 (Ruiz De Oña et al., 1988). The reason
why the fetal brain is not permeable to T3 is not known
and cannot be explained by lack of the Mct8 transporter as
this is present at the BBB during fetal development (Grijota-
Martínez et al., 2011). Likewise for the mouse, recent studies have
demonstrated that maternal T4 is an essential source of TH in
the developing mouse fetal brain and that T3 content is regulated
through the conversion of T4 into T3 by D2 activity (Bárez-
López et al., 2017b). However, the contribution of maternal
T3 to the total fetal brain T3 content in mice still remains to be
elucidated.
It still remains unclear whether maternal THs are necessary
before the onset of the fetal thyroid gland. Some studies in
rats indicated that maternal hypothyroidism leads to defects in
the proliferation of some neuronal precursors that is usually
completed by E12 (Narayanan and Narayanan, 1985), and
to defects in the migration of some proliferating cells that
normally finishes at E16–E17 (Lucio et al., 1997). In mice
the treatment of pregnant dams with goitrogens from E13 to
E16 led to a decrease in the T4 content in the fetal CCx
and had an effect in the expression of a few T3-dependent
genes (Dong et al., 2015). These findings might indicate that
maternal THs are necessary before the fetal thyroid gland
starts functioning, however, these defects could arise from
maternal hypothyroidism side effects or from a direct effect
of the goitrogens used to induce hypothyroidism. However
one study in rats evidenced that maternal hypothyroxinemia
derived from low iodine intake results in abnormal migration
of neurons that is usually complete before the fetal thyroid
function, strongly suggesting that maternal THs are necessary
before the onset of the fetal thyroid gland (Lavado-Autric et al.,
2003).
Another essential aspect that needs to be clarified is the
contribution of maternal THs to the fetal brain under fetal
euthyroid conditions. Studies in rats revealed that fetuses coming
from thyroidectomized pregnant dams presented only a small
decrease in the brain content of T4, with no changes in
T3 content at perinatal stages (Berbel et al., 2010; Grijota-
Martínez et al., 2011) and unaffected expression of T3-dependent
genes (Morte et al., 2010b; Grijota-Martínez et al., 2011).
Likewise, in another study, brain D2 activity of fetuses coming
from thyroidectomized pregnant rats was not different from
those coming from control dams (Ruiz De Oña et al., 1988).
These findings in rats can be attributed to the progressive
activity of the fetal thyroid gland indicating that fetal THs are
the main regulators of TH-dependent fetal gene expression.
Nevertheless, these results do not rule out a specific contribution
from the mother. As the contribution of the fetal thyroid gland
seems to be larger in rats than in mice (Bárez-López et al.,
2017b), it should not be assumed that mice will follow the
same pattern as rats. The difficulty of performing successful
thyroidectomies in mice might hinder the assessment of the
role of maternal THs in mice fetal brain under euthyroid fetal
conditions.
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BRAIN BARRIERS AND THYROID
HORMONES
The passage of substances from the blood to the brain is regulated
by the BBB and the blood-cerebrospinal fluid barrier (BCSFB).
The BBB is formed by endothelial cells within CNS microvessels
while the BCSFB is formed by a single epithelial cell layer in the
choroid plexus andmultiple epithelial cell layers in the arachnoid
membrane (Johanson et al., 2011). These barriers tightly control
the influx and efflux of molecules and ions at the blood-brain
interface to meet neural cell needs and to protect the brain
from toxins and pathogens (Obermeier et al., 2013). The severe
alterations present in MCT8-deficient patients (Fu et al., 2013)
revealed the relevance of TH transporters and the importance of
TH transport across brain barriers (Ceballos et al., 2009; Iwayama
et al., 2016; Vatine et al., 2017). Studies in the rat indicated that
the contribution of the choroid plexus to the total brain TH
content is about 18% (Chanoine et al., 1992) and, since the BBB
surface area is much greater than that of the choroid plexus, the
BBB has been considered the major pathway for TH entry into
the brain (Dratman et al., 1991).
However, what is the situation in the fetal brain during the
development of the BBB (Obermeier et al., 2013) and before the
maturation of astrocytes (Daneman et al., 2010)? In a recent
study we detected Dio2 mRNA in the mouse brain in the
meninges, the ependymal layer of the lateral ventricles and the
choroid plexus at E15 and E18 (Bárez-López et al., 2017b). Dio2
expression in the meninges, the ependymal layer of the lateral
ventricles and the choroid plexus diminished by P3 and has
not been detected in these structures in the adult brain neither
in mice (Bárez-López et al., 2017a) nor rats (Wittmann et al.,
2014). This indicates an important role of D2 at the BCSFB
during fetal stages, especially since it has been suggested that the
BCSFB could have a more important role during early stages of
brain growth and development as the choroid plexus may have
a greater transport capacity (Keep and Jones, 1990). Moreover,
the volume of the lateral ventricles is larger at these stages
in comparison to the rest of the brain (O’Rahilly and Müller,
2008). This suggests that the T4 transported through the choroid
plexus could be deiodinated into T3 by D2 activity at the BCSFB
and from the cerebrospinal fluid the T3 could reach the brain
cells and exert and action at the genomic level (Figure 2).
Furthermore, the generation of T3 by D2 at the meninges could
be controlling the synthesis of retinoid acid (Gil-Ibáñez et al.,
2014) regulating cortical neurogenesis (Siegenthaler et al., 2009).
It has also been demonstrated that D2 deficiency during perinatal
neurodevelopment leads to a state of brain hypothyroidism with
reduced expression of T3-dependent genes (Bárez-López et al.,
2017b). Altogether the current data indicate that conversion of
T4 into T3 by D2 activity might be the only source of T3 during
mouse brain development.
CONCLUSION
Due to the crucial role of TH action during brain development
and to consequences of TH deficit, it is essential to
understand the physiological mechanisms that underlie
T4 and T3 availability to the developing brain in order to
obtain insight into pathological conditions. This will permit the
development of appropriate treatments and establish timings
to prevent, restore or at least palliate possible impairments, for
example for MCT8-deficient patients. Studies in animal models
have provided a great deal of information about the events
underlying TH action during brain development, however,
there are still many aspects that need to be elucidated. Among
all the unresolved matters both in rat and mouse, a better
understanding of the contribution of maternal THs to the fetal
brain under euthyroid conditions, of the role of TH transporters
during brain development and of the contribution of the
BCSFB to TH brain availability would facilitate potential clinical
applications in the future.
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